In the spring of 2026, thirteen research teams at Queen's University in Kingston, Ontario were awarded $12.7 million through Canada's most competitive health research funding body, the Canadian Institutes of Health Research. The grants span some of medicine's most persistent challenges — stroke recovery, brain tumour recurrence, cancer surveillance, sepsis, and the burdens of dialysis in old age — each project designed not merely to understand disease but to change how it is treated. It is a moment that speaks to a quiet but consequential truth: that the distance between a laboratory discovery
Queen's University secures $12.7M in competitive CIHR health research grants
Moving from discovery into clinical practice within a reasonable timeframe
Mark
What makes these grants different from other research funding?
Mimi
CIHR money is highly competitive—there are far more worthy proposals than dollars available. Winning means your question passed rigorous peer review. But the real distinction is the word 'translational.' These aren't pure basic science. They're designed to move from discovery into clinical practice within a reasonable timeframe.
Mark
So the glioblastoma project—why does it matter if we know why tumours come back?
Mimi
Because right now, surgeons remove what they can see, but cancer cells remain at the margins and in surrounding tissue. If we understand what drives recurrence at the molecular level, we can potentially target those cells with precision medicine instead of just hoping surgery was enough.
Mark
And the dialysis study—that seems almost simple by comparison.
Mimi
It's deceptively important. Dialysis is gruelling for elderly patients. If they can maintain their health on fewer sessions per week, that's a massive quality-of-life gain. But you have to prove it works first, rigorously, in a randomized trial.
Mark
Why is Kingston Health Sciences Centre mentioned so prominently?
Mimi
Because these researchers don't work in isolation. They have direct access to patients, clinical data, and the infrastructure of a major hospital. That proximity collapses the distance between discovery and application. A finding in the lab can reach a patient bedside faster.
Mark
Does winning this money guarantee results?
Mimi
No. It guarantees the work will happen, that the team has credibility, that the question is worth asking. Results are never guaranteed. But these are the kinds of bets that move medicine forward.
O Pulso
- Thirteen Queen's University teams competed in one of Canada's most selective grant processes and emerged with $12.7 million — a result that signals both scientific credibility and institutional momentum.
- The projects tackle conditions that carry enormous human cost: glioblastoma that returns after surgery, lung cancer that resists immunotherapy, septic shock that overwhelms intensive care units, and dialysis schedules that exhaust elderly patients.
- Each grant is structured around translational intent — moving findings from bench to bedside — with Kingston Health Sciences Centre serving as the clinical bridge where laboratory answers meet real patients.
- The Sinclair Cancer Research Institute anchors five of the thirteen projects, while departments from computing to rehabilitation therapy reflect the deliberately cross-disciplinary architecture of the research portfolio.
- The true test lies ahead: whether stroke patients regain more function, whether cancer patients live longer, and whether older adults on dialysis can carry a lighter treatment burden without losing ground.
In the spring of 2026, thirteen research teams at Queen's University in Kingston, Ontario were awarded $12.7 million through Canada's most competitive health research funding body, the Canadian Institutes of Health Research. The grants span some of medicine's most persistent challenges — stroke recovery, brain tumour recurrence, cancer surveillance, sepsis, and the burdens of dialysis in old age — each project designed not merely to understand disease but to change how it is treated. It is a moment that speaks to a quiet but consequential truth: that the distance between a laboratory discovery and a patient's improved life is shortened, above all, by sustained institutional commitment and the courage to ask hard clinical questions.
Thirteen research teams at Queen's University have secured $12.7 million in grants from the Canadian Institutes of Health Research, the country's primary health science funder, through the intensely competitive CIHR Project Grant competition in spring 2026. The projects range across some of medicine's most difficult terrain: brain reorganization after stroke, the molecular reasons glioblastoma tumours return after surgery, liquid biopsy methods for tracking lung cancer response to immunotherapy, and more individualized treatment protocols for endometrial cancer.
One of the more immediately practical projects asks whether elderly dialysis patients can maintain their health on a reduced treatment schedule — a question with direct consequences for quality of life in aging populations. That project alone received nearly $941,000. Other funded work examines how extracellular vesicles protect blood-forming stem cells, tests methylene blue as a treatment adjunct in septic shock, and develops a virtual screening program to catch developmental delays in medically complex children.
Nancy Ross, Queen's Vice-Principal for Research, acknowledged that CIHR grants are scarce and fiercely sought across the country. The university's success reflects both the calibre of its researchers and the infrastructure surrounding them — particularly the partnership with Kingston Health Sciences Centre, which allows findings to move from laboratory to clinical practice with unusual speed, and brings real-world clinical problems back into the research environment.
The Sinclair Cancer Research Institute is involved in five of the thirteen projects. Across the portfolio, teams will develop personalized prostate cancer surveillance using multi-modal imaging, investigate how pain-sensing neurons shape the immune environment around tumours, and build neuro-computational models of how the brain acquires motor skills. For Queen's, the $12.7 million is a moment of validation — but the deeper measure will arrive when patients recover better, live longer, or carry less burden. These grants are the down payment on that promise.
Thirteen research teams at Queen's University have landed a combined $12.7 million in grants from the Canadian Institutes of Health Research, the country's primary funding body for health science investigation. The money arrived through CIHR's Project Grant competition in spring 2026, and the projects span a striking range of medical challenges: how the brain rewires itself after stroke, why some brain tumours return despite surgery, whether dialysis patients might thrive on less frequent treatment, and the molecular mechanics of cancer spread and recurrence.
These are not theoretical exercises. Each project is designed to move from laboratory discovery into clinical practice—what researchers call translational work. A team led by Douglas Cook in surgery and Jason Gallivan in biomedical sciences will map the brain's reorganization following stroke and connect those changes to how well patients recover function. Another group, led by Teresa Purzner and James Purzner in surgery, will dissect why glioblastoma tumours sometimes regrow after surgical removal, examining the molecular and functional profiles of cancer cells at the margins of resected tissue and in infiltrated brain matter. Christopher Mueller's team will test a liquid biopsy method to monitor how lung cancer patients respond to immunotherapy. Wendy Parulekar and Josee-Lyne Ethier will refine treatment decisions for endometrial cancer based on molecular characteristics rather than one-size-fits-all protocols.
The dialysis project, led by Christine White and Rachel Holden, asks a practical question with real consequences for aging patients: can older adults maintain their health on a reduced treatment schedule? That work alone received nearly $941,000. Other grants support investigation into how extracellular vesicles protect blood-forming stem cells, a virtual screening program to catch developmental delays in medically complex children, and a pilot trial testing methylene blue as an adjunct treatment in septic shock.
Nancy Ross, Queen's Vice-Principal for Research, noted that CIHR Project Grants are intensely competitive across Canada. The university's success reflects both the quality of its researchers and the institutional infrastructure supporting them. Many of these projects will unfold at Kingston Health Sciences Centre, the regional tertiary care hospital that partners closely with Queen's. That proximity matters: it means researchers can move findings from the bench into patient care relatively quickly, and clinicians can bring real-world problems back to the laboratory.
The thirteen projects represent a cross-section of Queen's research strength. The Sinclair Cancer Research Institute alone is involved in five of them. Departments ranging from critical care medicine to rehabilitation therapy to computing are represented. Parvin Mousavi's team will develop personalized prostate surveillance using multi-modal imaging aligned with pathology findings. Sébastien Talbot will investigate how nociceptor neurons—pain-sensing cells—influence the immune cells that cluster around tumours. Jason Gallivan has a second grant to build a neuro-computational model of how the brain learns motor skills, breaking apart memory expression, updating, and creation.
For a university research enterprise, this kind of funding announcement marks a moment of validation. CIHR money is scarce and sought after. Winning $12.7 million signals that Queen's teams are asking the right questions and have the capacity to answer them. The real measure, though, will come later: when stroke patients recover better function, when cancer patients live longer, when elderly dialysis patients can reduce their treatment burden without losing ground. That is what translational research promises. These grants are the down payment.
Citações Notáveis
CIHR Project Grants are highly competitive across Canada— Nancy Ross, Vice-Principal (Research) at Queen's University
Quer a matéria completa?
Leia o original em Education News Canada ↗
Health & Medicine